Organovo announces 1-for-12 reverse stock split effective March 20, 2025 to regain Nasdaq compliance

VivoSim Labs, INC.

1-for-12 reverse stock split effective 5:00 p.m. ET on March 20, 2025; adjusted trading begins March 21.
Outstanding shares reduce from ~21.4M to ~1.8M; fractional shares paid in cash at March 19 closing price.
Approved by shareholders on Nov 20, 2024; board selected 1-for-12 ratio on March 6, 2025.
Intended to regain compliance with Nasdaq $1.00 minimum bid price for continued listing on Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.